{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:28:15Z","timestamp":1789716495754,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":415,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009579","name":"Oxalosis and Hyperoxaluria Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009579","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Soci\u00e9t\u00e9 Fran\u00e7aise de N\u00e9phrologie"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bbadis.2013.04.010","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T03:53:25Z","timestamp":1366170805000},"page":"1776-1783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1"],"prefix":"10.1016","volume":"1832","author":[{"given":"Sonia","family":"Fargue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gill","family":"Rumsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Danpure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2013.04.010_bb0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0014-5793(86)80563-4","article-title":"Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I","volume":"201","author":"Danpure","year":"1986","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/cs0380277","article-title":"The action of pyridoxine in primary hyperoxaluria","volume":"38","author":"Gibbs","year":"1970","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0015","first-page":"259","article-title":"Studies on some possible biochemical treatments of primary hyperoxaluria","volume":"48","author":"Watts","year":"1979","journal-title":"Q. J. Med"},{"key":"10.1016\/j.bbadis.2013.04.010_bb0020","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/ndt\/10.12.2224","article-title":"Changing pattern of primary hyperoxaluria in Switzerland","volume":"10","author":"Kopp","year":"1995","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0025","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00467-003-1234-x","article-title":"A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria","volume":"18","author":"Hoppe","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0030","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1523-1755.2004.00796.x","article-title":"Clinical implications of mutation analysis in primary hyperoxaluria type 1","volume":"66","author":"van Woerden","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000085411","article-title":"Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria","volume":"25","author":"Monico","year":"2005","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0040","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1523-1755.2005.00267.x","article-title":"Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele","volume":"67","author":"Monico","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0045","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1373\/clinchem.2006.084434","article-title":"Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1","volume":"53","author":"Williams","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0050","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.clinbiochem.2008.01.018","article-title":"Mutation-based diagnostic testing for primary hyperoxaluria type 1: survey of results","volume":"41","author":"Coulter-Mackie","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0055","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ki.2009.435","article-title":"Genotype-phenotype correlation in primary hyperoxaluria type 1: the pGly170Arg AGXT mutation is associated with a better outcome","volume":"77","author":"Harambat","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0060","first-page":"417","article-title":"Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation","volume":"53","author":"Danpure","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0065","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1083\/jcb.111.6.2341","article-title":"Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine\/glyoxylate aminotransferase in primary hyperoxaluria type 1","volume":"111","author":"Purdue","year":"1990","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0070","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1083\/jcb.108.4.1345","article-title":"An enzyme trafficking defect in two patients with primary hyperoxaluria type 1: peroxisomal alanine\/glyoxylate aminotransferase rerouted to mitochondria","volume":"108","author":"Danpure","year":"1989","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0075","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1074\/jbc.M112.432617","article-title":"Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele","volume":"288","author":"Fargue","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"Pt. 2","key":"10.1016\/j.bbadis.2013.04.010_bb0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/0264-6021:3520409","article-title":"The peroxisomal targeting sequence type 1 receptor, Pex5p, and the peroxisomal import efficiency of alanine:glyoxylate aminotransferase","volume":"352","author":"Knott","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0085","doi-asserted-by":"crossref","first-page":"36415","DOI":"10.1074\/jbc.M006693200","article-title":"Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations","volume":"275","author":"Lumb","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/bj20030371","article-title":"Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro","volume":"374","author":"Lumb","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/BJ20051397","article-title":"Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells","volume":"394","author":"Behnam","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10545-012-9493-y","article-title":"Measurement of plasma B(6) vitamer profiles in children with inborn errors of vitamin B(6) metabolism using an LC-MS\/MS method","volume":"36","author":"Footitt","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0260","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biocel.2011.12.007","article-title":"The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase","volume":"44","author":"Montioli","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","article-title":"A guided tour into subcellular colocalization analysis in light microscopy","volume":"224","author":"Bolte","year":"2006","journal-title":"J. Microsc."},{"issue":"Pt. 4","key":"10.1016\/j.bbadis.2013.04.010_bb0115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/000456329703400411","article-title":"A semiautomated alanine:glyoxylate aminotransferase assay for the tissue diagnosis of primary hyperoxaluria type 1","volume":"34","author":"Rumsby","year":"1997","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0120","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(78)92211-0","article-title":"Vitamin B6 in management of gyrate atrophy of choroid and retina","volume":"2","author":"Weleber","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2013.04.010_bb0125","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/S0021-9258(19)75329-0","article-title":"The cofactor-mediated regulation of apoenzyme levels in animal tissues i the pyridoxine-induced rise of rat liver tyrosine transaminase level in vivo","volume":"238","author":"Greengard","year":"1963","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0130","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1172\/JCI109573","article-title":"delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia hypercatabolism caused by the increased susceptibility to the controlling protease","volume":"64","author":"Aoki","year":"1979","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10545-005-0243-2","article-title":"B6-responsive disorders: a model of vitamin dependency","volume":"29","author":"Clayton","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0140","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1172\/JCI118258","article-title":"Late-onset X-linked sideroblastic anemia Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts","volume":"96","author":"Cotter","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0014-5793(97)00181-6","article-title":"Degradation of tyrosine aminotransferase (TAT) via the ubiquitin\u2013proteasome pathway","volume":"405","author":"Gross-Mesilaty","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0150","first-page":"529","article-title":"Gyrate atrophy of the choroid and retina with hyperornithinemia: biochemical and histologic studies and response to vitamin B6","volume":"32","author":"Kennaway","year":"1980","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0155","first-page":"929","article-title":"Pyridoxine effects on ornithine ketoacid transaminase activity in fibroblasts from carriers of two forms of gyrate atrophy of the choroid and retina","volume":"43","author":"Shih","year":"1988","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0160","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1073\/pnas.85.11.3777","article-title":"Molecular basis of ornithine aminotransferase deficiency in B-6-responsive and -nonresponsive forms of gyrate atrophy","volume":"85","author":"Ramesh","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0165","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood.V90.2.822","article-title":"Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene","volume":"90","author":"Furuyama","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2013.04.010_bb0170","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1073\/pnas.1131968100","article-title":"Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase","volume":"100","author":"Santana","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ymgme.2006.07.013","article-title":"Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase: study of a spectrum of mutations","volume":"89","author":"Coulter-Mackie","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0180","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ymgme.2008.03.010","article-title":"Partial trypsin digestion as an indicator of mis-folding of mutant alanine:glyoxylate aminotransferase and chaperone effects of specific ligands: study of a spectrum of missense mutants","volume":"94","author":"Coulter-Mackie","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0185","doi-asserted-by":"crossref","first-page":"30493","DOI":"10.1074\/jbc.M803525200","article-title":"In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase","volume":"283","author":"Hopper","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0190","doi-asserted-by":"crossref","first-page":"8349","DOI":"10.1074\/jbc.M808965200","article-title":"Molecular Insight into the synergism between the minor allele of human liver peroxisomal alanine:glyoxylate aminotransferase and the F152I mutation","volume":"284","author":"Cellini","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0195","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1172\/JCI109906","article-title":"Plasma content of B6 vitamers and its relationship to hepatic vitamin B6 metabolism","volume":"66","author":"Lumeng","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0009-8981(90)90281-V","article-title":"Liquid chromatographic studies of vitamin B6 metabolism in man","volume":"190","author":"Edwards","year":"1990","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2013.04.010_bb0205","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00297371","article-title":"Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria","volume":"18","author":"Edwards","year":"1990","journal-title":"Urol. Res."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1373\/49.1.155","article-title":"Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study","volume":"49","author":"Bor","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0215","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1373\/clinchem.2005.051169","article-title":"Multianalyte quantification of vitamin B6 and B2 species in the nanomolar range in human plasma by liquid chromatography-tandem mass spectrometry","volume":"51","author":"Midttun","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0220","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10545-011-9279-7","article-title":"Pyridoxal 5\u2032-phosphate in cerebrospinal fluid; factors affecting concentration","volume":"34","author":"Footitt","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0225","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1093\/ndt\/gfs320","article-title":"Primary hyperoxaluria Type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort","volume":"27","author":"van der Hoeven","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0230","doi-asserted-by":"crossref","first-page":"28386","DOI":"10.1074\/jbc.M112.351056","article-title":"\u03b1-Galactosidase aggregation is a determinant of pharmacological chaperone efficacy on Fabry disease mutants","volume":"287","author":"Siekierska","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0300-9084(93)90091-6","article-title":"Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase","volume":"75","author":"Danpure","year":"1993","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2013.04.010_bb0240","doi-asserted-by":"crossref","first-page":"20587","DOI":"10.1074\/jbc.274.29.20587","article-title":"Effect of N-terminal alpha-helix formation on the dimerization and intracellular targeting of alanine:glyoxylate aminotransferase","volume":"274","author":"Lumb","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pep.2004.11.004","article-title":"Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor","volume":"41","author":"Coulter-Mackie","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbadis.2013.04.010_bb0250","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1073\/pnas.0908565107","article-title":"Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I","volume":"107","author":"Cellini","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T21:54:49Z","timestamp":1644789289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443913001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0925443913001348"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.04.010","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}